InvestSMART

Cryosite Limited (ASX:CTE)

ALERT: Price-sensitive ASX Announcement for CTE
Current share price for CTE : $1.060 0.31 (41.33%)+
Announcement
Release
21 Aug 2025 4:48PM
Price at Release
$0.750
Full Release
download
Summary
Cryosite Limited’s Appendix 4E and Annual Report for the year ended 30 June 2025 details a period of growth and profitability, with increased revenues and net profit. The report outlines the company’s activities in specialty logistics and storage for the healthcare sector, reviews its financial performance, and discusses operational highlights, governance, and risk management. No dividends were paid or proposed, and the company continued to invest in infrastructure and technology. The audited financial statements received an unmodified opinion, and the report provides comprehensive disclosures on director activities, remuneration, and future outlook.
Key Points
  • Cryosite Limited released its Appendix 4E and Annual Report for the financial year ended 30 June 2025.
  • The company reported total revenues of $9,315,352, showing an increase compared to the previous year.
  • Net profit after tax attributable to members was $1,010,574, reflecting improved profitability.
  • Cryosite provides specialty logistics, biobanking, clinical trials support, and storage services in the healthcare and biotechnology sector.
  • The report outlines the company's principal activities, financial position, and performance highlights.
  • Directors’ declarations, remuneration reports, and details of dividends are included.
  • No dividends were paid or proposed for the period.
  • Material risks and uncertainties were discussed, including business environment and operational risks.
  • The company emphasized ongoing investments in infrastructure and technology to support growth.
  • Corporate governance, environmental and social responsibility, and compliance statements are presented.
  • Cryosite did not experience any significant changes in its operational or financial structure during the year.
  • The report contains the auditor’s statement providing an unmodified opinion on the financial statements.
  • Details on board composition, meetings, and director interests are disclosed.
  • The Annual Report includes management’s review of operations and future prospects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.